Status:

COMPLETED

Behavioural Economics-based Incentives in Adults With Type 2 Diabetes (BET2)

Lead Sponsor:

The University of Hong Kong

Collaborating Sponsors:

University Grants Committee, Hong Kong

Conditions:

Diabetes Mellitus, Type 2

Eligibility:

All Genders

30-70 years

Phase:

NA

Brief Summary

A randomised control trial of adults with newly diagnosed type 2 diabetes to assess the effectiveness of behavioural economics-based incentives on healthy lifestyle behaviour, using a pragmatic trial ...

Detailed Description

This is a randomised control trial of adults aged 30-70 with newly diagnosed type 2 diabetes within a year in Hong Kong to compare the effectiveness of financial incentives and combined financial and ...

Eligibility Criteria

Inclusion

  • Chinese adults aged 30-70 years
  • Capable of providing informed consent
  • Resident in Hong Kong
  • Able to communicate in English or Chinese
  • Diagnosed with type 2 diabetes within past year
  • 5% ≤ HbA1c ≤ 9.0%
  • Willing to take blood tests
  • Access to a phone to track physical activity and receive text messages
  • Physically mobile for duration of the trial

Exclusion

  • Planned surgery in the next 6 months
  • Biological impairment or health condition affecting the ability to walk, such as blindness, physical immobility, and paralysis
  • Pregnant or breastfeeding
  • On insulin for diabetes control

Key Trial Info

Start Date :

June 21 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 31 2023

Estimated Enrollment :

122 Patients enrolled

Trial Details

Trial ID

NCT04917926

Start Date

June 21 2021

End Date

December 31 2023

Last Update

May 9 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong

Hong Kong, Hong Kong